Hualan Vac(SZ:301207) Xin Lang Cai Jing·2025-08-28 10:33Group 1 - Hualan Vaccine (301207.SZ) reported its semi-annual results for 2025, revealing that as of August 27, 2025, 13 institutional investors held a total of 520 million shares, accounting for 86.46% of the total share capital [1] - The top ten institutional investors include Hualan Biological Engineering Co., Ltd., CYBER CREATOR LIMITED, and several others, with their combined holding ratio increasing by 0.11 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, Southern CSI 1000 ETF, increased its holdings, while two funds, including China Merchants National Biomedicine Index A and Tianhong National Biomedicine ETF, reduced their holdings slightly [2] - Four new public funds were disclosed compared to the previous quarter, including Huaxia CSI 1000 ETF and several others [2] - On the foreign investment side, Hong Kong Central Clearing Limited was the only foreign fund to increase its holdings slightly [2]